Search Results

Retraction notice to "Coagulation–fibrinolysis abnormalities in patients receiving antiparkinsonian agents" [Journal of the Neurological Sciences 212 (2003), 55–58].

• Authors : Sato, Yoshihiro^1,2 (AUTHOR); Kaji, Masahide² (AUTHOR); Metoki, Norifumi³ (AUTHOR)

Subjects: *ANTIPARKINSONIAN agents; *NEUROSCIENCES; *HUMAN abnormalities

• Source: Journal of the Neurological Sciences. Jan2024, Vol. 456, pN.PAG-N.PAG. 1p.

Record details

Study of new p-tolylpiperidin-4-one as an anti-Parkinson agent: Synthesis, spectral, XRD-crystal, in silico study, electronic and intermolecular interaction investigations by the DFT method.

• Authors : Ramalingam, Arulraj¹ (AUTHOR) ; Arumugam, Thangamani^1,2 (AUTHOR) ; Sagaama, Abir³ (AUTHOR)

Subjects: *ANTIPARKINSONIAN agents; *INTERMOLECULAR interactions; *CHEMICAL stability

• Source: Materials Chemistry & Physics. Jul2024, Vol. 320, pN.PAG-N.PAG. 1p.

Record details

Potential antiparkinsonian agents derived from South African medicinal plants.

• Authors : Enogieru, Adaze Bijou; Omoruyi, Sylvester Ifeanyi; Hiss, Donavon Charles

Subjects: MEDICINAL plants; PARKINSON'S disease; PLANTS

• Source: Journal of Herbal Medicine; Sep2018, Vol. 13, p1-7, 7p

Record details

CVT-301 for Parkinson's disease: dose and effect size issues.

• Authors : Rascol, Olivier¹ (AUTHOR)

Subjects: *DOPA; *ANTIPARKINSONIAN agents; *PARKINSON'S disease

• Source: Lancet Neurology. Feb2019, Vol. 18 Issue 2, p128-130. 3p.

Record details

Parkinsonism Hyperpyrexia Syndrome following Deep Brain Stimulation.

• Authors : Govindappa, Shyla T.^1,2,3; Abbas, Masoom M.^1,2,3; Hosurkar, Guruprasad^1,2,3

Subjects: *PARKINSON'S disease treatment; *ANTIPARKINSONIAN agents; *DISEASE complications

• Source: Parkinsonism & Related Disorders. Oct2015, Vol. 21 Issue 10, p1284-1285. 2p.

Record details

Homology modeling, virtual screening, molecular docking, molecular dynamic (MD) simulation, and ADMET approaches for identification of natural anti-Parkinson agents targeting MAO-B protein.

• Authors : El Aissouq, Abdellah¹ (AUTHOR) ; Bouachrine, Mohammed² (AUTHOR); Ouammou, Abdelkrim³ (AUTHOR)

Subjects: *ANTIPARKINSONIAN agents; *MOLECULAR docking; *NEURODEGENERATION

• Source: Neuroscience Letters. Aug2022, Vol. 786, pN.PAG-N.PAG. 1p.

Record details

Synthesis of new azetidinonyl/thiazolidinonyl quinazolinone derivatives as antiparkinsonian agents.

• Authors : Kumar, Sunil; Kaur, Hemlata; Kumar, Ashok

• Source: Arabian Journal of Chemistry; Oct2012, Vol. 5 Issue 4, p475-484, 10p

Record details

Assessment of rewarding and reinforcing properties of biperiden in conditioned place preference in rats

• Authors : Allahverdiyev, Oruc¹; Nurten, Asiye²; Enginar, Nurhan¹

Subjects: *ANTIPARKINSONIAN agents; *PARASYMPATHOLYTIC agents; *LABORATORY rats

• Source: Behavioural Brain Research. Dec2011, Vol. 225 Issue 2, p642-645. 4p.

Record details

Diphenhydramine in the treatment of akathesia induced by prochlorperazine

• Authors : Baden, Eric Y.¹; Prodany, Karla²; Wiener, Sage W.³

Subjects: *ANTIPARKINSONIAN agents; *ANTIPSYCHOTIC agents; *HOSPITAL emergency services

• Source: Journal of Emergency Medicine (0736-4679). Apr2005, Vol. 28 Issue 3, p347-348. 2p.

Record details

Malignant syndrome in Parkinson's disease

• Authors : Linazasoro, Gurutz¹

Subjects: *DRUG therapy for Parkinson's disease; *ANTIPARKINSONIAN agents; *DOPAMINE

• Source: Parkinsonism & Related Disorders. Dec2003, Vol. 10 Issue 2, p115-116. 2p.

Record details